übersetzen   16 Tage

Understanding Corporate VCs’ Investment Criteria

Corporate VCs often differ from traditional venture capitalists by prioritizing strategic value over purely financial returns. Michael Ryan, Vice President of Venture Capital & Business Development at Boston Scientific, emphasized the company’s active role in investing: “We’re one of the most active acquirers in the medtech industry, generally deploying somewhere north of $100 million a year into venture investments.” For more information visit here: https://tinyurl.com/5nbabbry

Gefällt mir